Dr Alexander Tarr Alex.Tarr@nottingham.ac.uk
ASSOCIATE PROFESSOR
Genetic diversity underlying the envelope glycoproteins of hepatitis C virus: Structural and functional consequences and the implications for vaccine design
Tarr, Alexander W.; Khera, Tanvi; Hueging, Kathrin; Sheldon, Julie; Steinmann, Eike; Pietschmann, Thomas; Brown, Richard J.P.
Authors
Tanvi Khera
Kathrin Hueging
Julie Sheldon
Eike Steinmann
Thomas Pietschmann
Richard J.P. Brown
Abstract
© 2015 by the authors. In the 26 years since the discovery of Hepatitis C virus (HCV) a major global research effort has illuminated many aspects of the viral life cycle, facilitating the development of targeted antivirals. Recently, effective direct-acting antiviral (DAA) regimens with >90% cure rates have become available for treatment of chronic HCV infection in developed nations, representing a significant advance towards global eradication. However, the high cost of these treatments results in highly restricted access in developing nations, where the disease burden is greatest. Additionally, the largely asymptomatic nature of infection facilitates continued transmission in at risk groups and resource constrained settings due to limited surveillance. Consequently a prophylactic vaccine is much needed. The HCV envelope glycoproteins E1 and E2 are located on the surface of viral lipid envelope, facilitate viral entry and are the targets for host immunity, in addition to other functions. Unfortunately, the extreme global genetic and antigenic diversity exhibited by the HCV glycoproteins represents a significant obstacle to vaccine development. Here we review current knowledge of HCV envelope protein structure, integrating knowledge of genetic, antigenic and functional diversity to inform rational immunogen design.
Citation
Tarr, A. W., Khera, T., Hueging, K., Sheldon, J., Steinmann, E., Pietschmann, T., & Brown, R. J. (2015). Genetic diversity underlying the envelope glycoproteins of hepatitis C virus: Structural and functional consequences and the implications for vaccine design. Viruses, 7(7), 3995-4046. https://doi.org/10.3390/v7072809
Journal Article Type | Review |
---|---|
Acceptance Date | Jul 8, 2015 |
Online Publication Date | Jul 17, 2015 |
Publication Date | 2015-07 |
Deposit Date | Nov 9, 2022 |
Publicly Available Date | Nov 11, 2022 |
Journal | Viruses |
Electronic ISSN | 1999-4915 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Volume | 7 |
Issue | 7 |
Pages | 3995-4046 |
DOI | https://doi.org/10.3390/v7072809 |
Public URL | https://nottingham-repository.worktribe.com/output/3129358 |
Publisher URL | https://www.mdpi.com/1999-4915/7/7/2809 |
Files
viruses-07-02809
(2.5 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search